Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3911-3915

  Fox, Alvin ^a   Fox, Karen ^a   Christensson, Bertil ^a   Harrelson, Davis ^a   Krahmer, Mark ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MURAMIC ACID;

ARTICLE; BACTERIAL CELL WALL; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; SYNOVIAL FLUID; SYNOVITIS;

EID: 0029736775     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3911-3915.1996     Document Type: Article

References (27)

1. 3H-labelled] in the mouse. Int. J. Immunopharmacol. 6:133-139.
2. Christensson, B., J. Gilbart, A. Fox, and S. L. Morgan. 1989. Mass spectrometric quantitation of muramic acid, a bacterial cell wall component in septic synovial fluids. Arthritis Rheum. 32:1268-1272.
3. Cromartie, W. K., J. G. Craddock, J. H. Schwab, S. K. Anderle, and C. Yang. 1977. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J. Exp. Med. 146:1585-1602.
4. Eisenberg, R., A. Fox, J. J. Greenblatt, S. K. Anderle, W. J. Cromartie, and J. H. Schwab. 1982. Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats. Infect. Immun. 38:127-135.
5. Fox, A., and G. Black. 1994. Identification and detection of carbohydrate markers for bacteria: derivatization and gas chromatography-mass spectrometry, p. 107-131. In C. Fenselau (ed.), Mass spectrometry for the characterization of microorganisms. American Chemical Society, Washington, D.C.
6. Fox, A., and K. Fox. 1991. Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl dipeptides in normal serum at current analytical limits. Infect. Immun. 59:1202-1205.
7. Fox, A., S. L. Morgan, and J. Gilbart. 1988. Preparation of alditol acetates and their analysis by gas chromatography and mass spectrometry, p. 87-117. In C. J. Bierman and G. McGinnis (ed.), Analysis of carbohydrates by GLC and MS. CRC Press, Boca Raton, Fla.
8. Fox, A., J. H. Schwab, and T. Cochran. 1980. Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry. Infect. Immun. 29:526-531.
9. Fox, A., L. Wright, and K. Fox. 1995. Gas chromatography tandem mass spectrometry for trace detection of muramic acid, a peptidoglycan chemical marker in organic dust. J. Microbiol. Methods 22:11-26.
10. Gilbart, J., and A. Fox. 1987. Elimination of group A streptococcal cell walls from mammalian tissues. Infect. Immun. 55:1526-1528.
11. Grantors, K., S. Jalkanen, R. Von Essen, R. Lahesmaa-Rantala, O. Isomäki, K. Pekkola-Heino, R. Merilahti-Palo, R. Saario, H. Isomäki, and A. Toivanen. 1989. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N. Engl. J. Med. 320:216-221.
12. Harrison, J., and A. Fox. 1985. Degradation of muramyl dipeptide by mammalian serum. Infect. Immun. 50:320-321.
13. Hoijer, M. A., M.-J. Melief, C. G. van Helden-Meeuwsen, F. Eulderink, and M. P. Hazenberg. 1995. Detection of muramic acid in a carbohydrate fraction of human spleen. Infect. Immun. 63:1652-1657.
14. Johannsen, L., R. S. Rasenthal, S. A. Martin, A. B. Cady, F. Obal, Jr., M. Guinand, and J. M. Krueger. 1989. Somnogenic activity of O-acetylated and dimeric muramyl dipeptides. Infect. Immun. 57:2726-2732.
15. 14C-labelled immunoadjuvant peptidoglycan monomer. II. In vitro studies. Biochim. Biophys. Acta 678:12-17.
16. Lehtonen, L., P. Kortekangas, P. Oksman, E. Eerola, H. Aro, and A. Toivanen. 1994. Synovial fluid muramic acid in acute inflammatory arthritis. Br. J. Rheumatol. 33:1127-1130.
17. Li, T., K. Fox, A. Fox, and V. Pakalnis. 1993. Recurrent anterior uveitis induced by multiple systemic injections of muramyl dipeptide. Exp. Eye Res. 57:79-87.
18. Lichlman, S. N, J. Wang, R. B. Sartor, C. Zhang, D. Bender, F. G. Dalldorf, and J. H. Schwab. 1995. Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers. Infect. Immun. 63:2295-2301.
19. Mollner, S., and V. Braun. 1984. Murein hydrolase (N-acetyl muramyl-L-alanine amidase) in human serum. Arch. Microbiol. 140:171-177.
20. Nikkari, S., R. Merilahti-Palo, R. Saario, et al. 1992. Yersinia-triggered reactive arthritis: use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial fluids. Arthritis Rheum. 35:682-687.
21. 14C-labelled) in the mouse. Int. J. Immunopharmacol. 1:35-41.
22. Schumacher, H. R., S. Magge, P. V. Cherian, J. Sleckman, S. Rothfuss, G. Clayburne, and M. Sieck. 1988. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Arthritis Rheum. 31:937-946.
23. Sen, Z., and M. L. Karnovsky. 1984. Qualitative detection of muramic acid in normal mammalian tissues. Infect. Immun. 43:937-941.
24. Steere, A. C., P. H. Dufray, and E. Butcher. 1988. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Arthritis Rheum. 31:487-495.
25. Taylor-Robinson, D., C. B. Gilroy, B. J. Thomas, and A. C. S. Keat. 1992. Detection of Chlamydia trachamatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 340:81-82.
26. 14C-labellcd peptidoglycan monomer in mice. I. Identification of the monomer and the corresponding pentapeptide in urine. Biochim. Biophys. Acta 629:77-82.
27. Zídek, Z., K. Mašek, and Z. Jiřička. 1982. Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide. Infect. Immun. 35:674-679.